Lyme Disease IgM Ab
Lyme Disease IgM Ab is a clinical biomarker on the Infection panel, reported in index. Standard reference range: 0–1.09 index. Functional (optimal) range used by integrative practitioners: 0–0 index.
What is Lyme Disease IgM Ab?
Lyme IgM antibodies indicate early or recent Borrelia burgdorferi infection; they appear within weeks of infection but may persist for months, causing false-positive interpretations.
Reference ranges
| Range type | Value (index) | Source |
|---|---|---|
| Standard (lab) | 0–1.09 | Typical Quest / LabCorp adult reference |
| Functional (optimal) | 0–0 | Integrative / functional medicine consensus |
How SomaVue interprets Lyme Disease IgM Ab
SomaVue maps every result for Lyme Disease IgM Ab against four clinical lenses — nutrient cofactors, toxin exposure, infection drivers, and circadian/hormonal context — and connects each interpretation to specific peer-reviewed citations. Pre-mapped clinical reasoning and cross-marker pattern detection are available inside the practitioner workspace.
See the full interpretation
Upload a patient PDF or enter values manually to see the four-lens analysis, cross-marker patterns, and cited evidence for Lyme Disease IgM Ab and 205 other markers.
Try it freeEducational reference only. Reference ranges vary by laboratory, assay method, age, sex, and clinical context. Functional ranges represent integrative-medicine consensus and are not regulatory thresholds. SomaVue does not diagnose, treat, mitigate, or prevent disease. Always consult a licensed healthcare provider.